METHOD FOR DIAGNOSING CARCINOMAS USING IRGD AND MAGNETIC RESONANCE TOMOGRAPHY (MRT)

摘要

The invention relates to an imaging diagnostic method comprising a contrast agent with a contrast enhancer in a magnetic resonance tomography (MRT)-assisted diagnosis of carcinoma diseases or carcinomas, particularly hepatocellular carcinoma (HCC). The contrast agent is preferably a gadolinium compound, preferably Gd-DTPA with iRGD as a contrast enhancer for improved imaging in the MRT of carcinomas, particularly HCC. The invention also relates to a method for the risk stratification of patients and subjects using said diagnosis.